DITROPAN XL
Live / Registered — Registered and renewed (as of 29 Jun 2019)
What this means for you
Registered since 03 Aug 1999. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 03 Aug 2019).
Record
- Serial number
- 75377413
- Registration number
- 2266320
- Mark type
- Word mark
- Filed
- 22 Oct 1997
- Published for opposition
- 11 May 1999
- Registered
- 03 Aug 1999
- Next maintenance due
- 03 Aug 2019
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, a controlled release form of oxybutynin for the treatment of urge urinary incontinence and overactive bladder
Owner
- ALZA Corporation, Vacaville, CA, US
- ALZA Corporation, Palo Alto, CA, US
- ALZA Corporation, Palo Alto, CA, US
Prior registrations
Prosecution history
- 29 Jun 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 29 Jun 2019 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 29 Jun 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 29 Jun 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 May 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 May 2019 — TEAS SECTION 8 & 9 RECEIVED
- 17 May 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 17 May 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Jul 2009 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 22 Jul 2009 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 14 Jul 2009 — ASSIGNED TO PARALEGAL
- 06 Jul 2009 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 06 Jul 2009 — PAPER RECEIVED
- 02 Apr 2005 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Apr 2005 — ASSIGNED TO PARALEGAL